Abivax - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAbivax

Abivax(ABVX)

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

anxiety disorders

,

healthy volunteers/patients

,

huntington disease

,

non-alcoholic fatty liver disease

,

,

,

,

,

breast neoplasms

,

,

chronic hepatitis b

,

chronic hepatitis

,

parkinson disease

,

eosinophilic esophagitis

,

,

biliary liver cirrhosis

,

,

,

pulmonary hypertension

,

pulmonary arterial hypertension

,

diffuse scleroderma

,

,

,

,

short bowel syndrome

,

myocardial infarction

,

drug resistance

,

heat stress disorders

,

,

combat disorders

,

traumatic stress disorders

,

gastrointestinal diseases

,

,

intestinal diseases

,

knee osteoarthritis

,

,

,

musculoskeletal diseases

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

depressive disorder

,

,

,

major depressive disorder

,

,

,

,

kidney diseases

,

,

cardiovascular diseases

,

chronic renal insufficiency

,

chronic hepatitis c

,

papillomavirus infections

,

,

,

pulmonary embolism

,

,

thromboembolism

,

,

venous thrombosis

,

,

papillomavirus vaccines

,

,

meningococcal infections

,

,

glucose metabolism disorders

,

metabolic diseases

,

vascular diseases

,

,

metabolic syndrome

,

endocrine system diseases

,

hypertriglyceridemia

,

rheumatoid arthritis

,

atrial fibrillation

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

systemic scleroderma

,

juvenile arthritis

,

behcet syndrome

,

dermatomyositis

,

ankylosing spondylitis

,

sjogren's syndrome

,

systemic lupus erythematosus

,

,

spondylarthritis

,

systemic vasculitis

,

diabetic neuropathies

,

hypercholesterolemia

,

,

facial nerve diseases

,

,

wasting syndrome

,

,

keratoconjunctivitis sicca

,

dry eye syndromes

healthy volunteers/patients

,

,

rheumatoid arthritis

,

,

,

,

,

acquired immunodeficiency syndrome

,

ulcerative colitis

,

,

ulcerative colitis

multiple sclerosis

,

,

,

Bos taurus adrenal cortex corticosteroids

,

atrial fibrillation

,

,

coronary artery disease

,

,

chronic renal insufficiency

,

chronic kidney failure

,

kidney transplantation

,

pulmonary fibrosis

,

secondary hyperparathyroidism

,

,

kidney diseases

,

renal insufficiency

,

,

bacillary dysentery

,

,

salmonella infections

,

herpesviridae infections

,

acquired immunodeficiency syndrome

,

haemophilus infections

,

meningococcal infections

,

,

neisseria meningitidis

,

papillomavirus infections

,

,

,

meningococcal meningitis

,

falciparum malaria

,

,

,

pneumococcal pneumonia

,

streptococcus pneumoniae

,

gram-negative bacterial infections

,

premature birth

,

,

,

papillomavirus vaccines

,

hematopoietic stem cell transplantation

,

,

,

,

,

,

haemophilus influenzae type b

,

chronic hepatitis b

,

chronic hepatitis

,

,

streptococcal infections

,

pneumococcal infections

,

,

rotavirus infections

,

human influenza

,

,

,

,

diabetes mellitus

,

liver cirrhosis

,

type 2 diabetes mellitus

,

healthy volunteers/patients

,

immunologic tests

,

non-alcoholic fatty liver disease

,

gastrointestinal neoplasms

,

,

neoplasm metastasis

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

respiratory distress syndrome

,

,

severe acute respiratory syndrome

,

communicable diseases

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use